Sex (male: female)
|
771:1864
|
559:515
|
518:1385
|
423:396
|
Age at study entry (years)
|
40.6 ± 12.4
|
6.7 ± 4.1
|
41.0 ± 12.3
|
6.5 ± 4.0
|
Age at 8-year follow-up (years)
|
48.3 ± 12.4
|
14.2 ± 4.2
|
48.8 ± 12.3
|
14.1 ± 4.2
|
Marital status (living in partnership)
|
1916 (72.7%)
| |
1405 (73.9%)
| |
Education (attending school >10 years)
|
1570 (59.6%)
| |
1155 (60.7%)
| |
Belief in homeopathy at study entry
|
1744 (66.2%)
|
739 (68.8%)
|
1283 (67.4%)
|
567 (69.2%)
|
Duration of disease at study entry (years)
|
10.0 ± 9.6
|
4.3 ± 2.7
|
9.8 ± 8.7
|
4.2 ± 3.5
|
Intake of conventional drugs at study entry
|
1318 (50.0%)
|
340 (31.7%)
|
965 (50.7%)
|
273 (33.3%)
|
Primary diagnosis at study entry *
| | | | |
Allergies (ICD9: 995.3)
|
154 (5.8%)
|
65 (6.1%)
|
114 (6.0%)
|
51 (6.2%)
|
Anxiety (ICD9: 300.0)
|
137 (5.2%)
|
44 (4.1%)
|
94 (4.9%)
|
34 (4.2%)
|
Asthma (ICD9: 493.9)
|
109 (4.1%)
|
67 (6.2%)
|
88 (4.6%)
|
51 (6.2%)
|
Depression (ICD9: 311.0)
|
157 (6.0%)
|
5 (0.5%)
|
110 (5.8%)
|
2 (0.2%)
|
Eczema (ICD9: 692.9)
|
200 (7.6%)
|
48 (4.5%)
|
154 (8.1%)
|
42 (5.1%)
|
Multiple infections (ICD9: 796.6)
|
140 (5.3%)
|
183 (17.0%)
|
105 (5.5%)
|
141 (17.2%)
|
Migraine (ICD9: 346.9)
|
202 (7.7%)
|
16 (1.5%)
|
146 (7.7%)
|
12 (1.5%)
|
Atopic dermatitis (ICD9: 691.8)
|
131 (5.0%)
|
216 (20.1%)
|
99 (5.2%)
|
175 (21.4%)
|
Allergic rhinitis (ICD9: 477.9)
|
215 (8.2%)
|
58 (5.4%)
|
161 (8.5%)
|
45 (5.5%)
|
Headache (ICD9: 784.0)
|
216 (8.2%)
|
71 (6.6%)
|
155 (8.1%)
|
45 (5.5%)
|
Sleep disorders (ICD9: 780.5)
|
185 (7.0%)
|
77 (7.2%)
|
127 (6.7%)
|
58 (7.1%)
|